Type 1 iodothyronine deiodinase in human physiology and disease

Journal of Endocrinology

Volumn 209, Issue 3, 2011, Pages 283-297

  Maia, Ana Luiza ^a   Goemann, Iuri Martin ^a   Meyer, Erika L Souza ^a   Wajner, Simone Magagnin ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

LIOTHYRONINE; THYROID HORMONE; THYROXINE; THYROXINE DEIODINASE; IODIDE PEROXIDASE; IODOTHYRONINE DEIODINASE TYPE I;

DNA POLYMORPHISM; HUMAN; HYPERTHYROIDISM; IODINE DEFICIENCY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; THYROID FUNCTION; THYROID HORMONE BLOOD LEVEL; BLOOD; GENERAL ASPECTS OF DISEASE; GENETICS; METABOLISM;

DISEASE; HUMANS; IODIDE PEROXIDASE; THYROID HORMONES;

EID: 79958213271     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-10-0481     Document Type: Review

References (175)

1. Abuid J & Larsen PR 1974 Triiodothyronine and thyroxine in hyperthyroidism. Comparison of the acute changes during therapy with antithyroid agents. Journal of Clinical Investigation 54. 201-208.
2. Aceves C, Escobar C, Rojas-Huidobro R, Vazquez-Martinez O, Martinez-Merlos T, Aguilar-Roblero R & Diaz-Munoz M 2003 Liver 5′-deiodinase activity is modified in rats under restricted feeding schedules: evidence for post-translational regulation. Journal of Endocrinology 179 91-96.
3. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E & Flier JS 1996 Role of leptin in the neuroendocrine response to fasting. Nature 82 250-252.
4. Alcantara MR, Salvatori R, Alcantara PR, Nobrega LM, Campos VS, Oliveira EC, Oliveira MH, Souza AH & Aguiar-Oliveira MH 2006 Thyroid morphology and function in adults with untreated isolated growth hormone deficiency. Journal of Clinical Endocrinology and Metabolism 91 860-864.
5. Ambroziak M, Pachucki J, Stachlewska-Nasfeter E, Nauman J & Nauman A 2005 Disturbed expression of type 1 and type 2 iodothyronine deiodinase as well as titf1/nkx2-1 and pax-8 transcription factor genes in papillary thyroid cancer. Thyroid 15 1137-1146.
6. Araujo RL, Andrade BM, da Silva ML, Ferreira AC & Carvalho DP 2009 Tissuespecific deiodinase regulation during food restriction and low replacement dose of leptin in rats.American Journal of Physiology. Endocrinology and Metabolism 296 E1157-E1163.
7. 3 production, and whole-body fat xidation. Endocrinology 151 3460-3469.
8. Arnaldi LA, Borra RC, Maciel RM & Cerutti JM 2005 Gene expression profiles reveal that DCN, DIO1, and DIO2 are underexpressed in benign and alignant thyroid tumors. Thyroid 15 210-221.
9. Arthur JR, Nicol F, Grant E & Beckett GJ 1991 The effects of selenium deficiency on hepatic type-I iodothyronine deiodinase and protein disulphide-isomerase assessed by activity measurements and affinity labelling. Biochemical Journal 15 297-300.
10. Baqui MM, Gereben B, Harney JW, Larsen PR & Bianco AC 2000 Distinct subcellular localization of transiently expressed types 1 and 2 iodothyronine deiodinases as determined by immunofluorescence confocal microscopy. Endocrinology 141 4309-4312.
11. Bates JM, St Germain DL & Galton VA 1999 Expression profiles of the three iodothyronine deiodinases, D1, D2 and D3, in the developing rat. Endocrinology 140 844-851.
12. Bates JM, Spate VL, Morris JS, St Germain DL & Galton VA 2000 Effects of selenium deficiency on tissue selenium content, deiodinase activity, and thyroid hormone economy in the rat during development. Endocrinology 141 2490-2500.
13. Baur A, Bauer K, Jarry H & Kohrle J 2000 Effects of proinflammatory cytokines on anterior pituitary 5′-deiodinase type I and type II. Journal of Endocrinology 167 505-515.
14. Baur A, Buchfelder M & Kohrle J 2002 Expression of 5′-deiodinase enzymes in normal pituitaries and in various human pituitary adenomas. European ournal of Endocrinology 147 263-268.
15. Beckett GJ, Beddows SE, Morrice PC, Nicol F & Arthur JR 1987 Inhibition of hepatic deiodination of thyroxine is caused by selenium deficiency in rats. iochemical Journal 248 443-447.
16. Beech SG, Walker SW, Arthur JR, Lee D & Beckett GJ 1995 Differential control of type-I iodothyronine deiodinase expression by the activation of the cyclic AMP and phosphoinositol signalling pathways in cultured human thyrocytes. Journal of Molecular Endocrinology 14 171-177.
17. Bermano G, Nicol F, Dyer JA, Sunde RA, Beckett GJ, Arthur JR & Hesketh JE 1995 Tissue-specific regulation of selenoenzyme gene expression during selenium deficiency in rats. Biochemical Journal 311 425-430.
18. Berry MJ, Kates AL & Larsen PR 1990 Thyroid hormone regulates type I deiodinase messenger RNA in rat liver. Molecular Endocrinology 4 743-748.
19. Berry MJ, Banu L & Larsen PR 1991a Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Nature 349 438-440.
20. Berry MJ, Banu L, Chen YY, Mandel SJ, Kieffer JD, Harney JW & Larsen PR 1991b Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3′ untranslated region. Nature 353 273-276.
21. Berry MJ, Kieffer JD, Harney JW & Larsen PR 1991c Selenocysteine confers the biochemical properties characteristic of the type I iodothyronine deiodinase. Journal of Biological Chemistry 266 14155-14158.
22. Berry MJ, Grieco D, Taylor BA, Maia AL, Kieffer JD, Beamer W, Glover E, Poland A & Larsen PR 1993 Physiological and genetic analyses of inbred mouse strains with a type I iodothyronine 5′ deiodinase deficiency. Journal of Clinical Investigation 92 1517-1528.
23. Bianco AC, Maia AL, da Silva WS & Christoffolete MA 2005 Adaptive activation of thyroid hormone and energy expenditure. Bioscience Reports 25. 191-08.
24. Boelen A, Platvoet-Ter Schiphorst MC & Wiersinga WM 1993 Association between serum interleukin-6 and serum 3,5,3′-triiodothyronine in nonthyroidal illness. Journal of Clinical Endocrinology and Metabolism 77 1695-1699.
25. Boelen A, Platvoet-Ter Schiphorst MC & Wiersinga WM 1995 Soluble cytokine receptors and the low 3,5,3′-triiodothyronine syndrome in patients with nonthyroidal disease. Journal of Clinical Endocrinology and Metabolism 80 971-976.
26. Butler PW, Smith SM, Linderman JD, Brychta RJ, Alberobello AT, Dubaz OM, Luzon JA, Skarulis MC, Cochran CS, Wesley RA et al. 2010 The Thr92Ala 5′ type 2 deiodinase gene polymorphism is associated with a delayed triiodothyronine secretion in response to the thyrotropinreleasing hormone-stimulation test: a pharmacogenomic study. Thyroid. 20 1407-1412.
27. Cabanelas A, Lisboa PC, Moura EG & Pazos-Moura CC 2006 Leptin acute modulation of the 5′-deiodinase activities in hypothalamus, pituitary and brown adipose tissue of fed rats. Hormone and Metabolic Research 38 481-485.
28. Callebaut I, Curcio-Morelli C, Mornon JP, Gereben B, Buettner C, Huang S, Castro B, Fonseca TL, Harney JW, Larsen PR et al. 2003 The iodothyronine selenodeiodinases are thioredoxin-fold family proteins containing a glycoside hydrolase clan GH-A-like structure. Journal of Biological Chemistry 278 36887-36896.
29. Calomme M, Vanderpas J, Francois B, Van Caillie-Bertrand M, Vanovervelt N, Van Hoorebeke C & Vanden Berghe D 1995 Effects of selenium supplementation on thyroid hormone metabolism in phenylketonuria subjects on a phenylalanine restricted diet. Biological Trace Element Research 47 349-353.
30. Cheng SY, Leonard JL & Davis PJ 2010 Molecular aspects of thyroid hormone actions. Endocrine Reviews 31 139-170.
31. Chopra IJ, Wu SY, Nakamura Y & Solomon DH 1978 Monodeiodination of 3,5,3′-triiodothyronine and 3,3′,5′-triiodothyronine to 3,3′-diiodothyronine n vitro. Endocrinology 102 1099-1106.
32. Chopra IJ, Sakane S & Teco GN 1991 A study of the serum concentration of tumor necrosis factor-alpha in thyroidal and nonthyroidal illnesses. Journal of linical Endocrinology and Metabolism 72 1113-1116.
33. Christoffolete MA, Arrojo e Drigo R, Gazoni F, Tente SM, Goncalves V, Amorim BS, Larsen PR, Bianco AC & Zavacki AM 2007 Mice with impaired extrathyroidal thyroxine to 3,5,3′-triiodothyronine conversion maintain normal serum 3,5,3′-triiodothyronine concentrations. Endocrinology 148 954-960.
34. Contempre B, Dumont JE, Ngo B, Thilly CH, Diplock AT & Vanderpas J 1991 Effect of selenium supplementation in hypothyroid subjects of an iodine and selenium deficient area: the possible danger of indiscriminate supplementation of iodine-deficient subjects with selenium. Journal of Clinical Endocrinology and etabolism 73 213-215.
35. Contempre B, Duale NL, Dumont JE, Ngo B, Diplock AT & Vanderpas J 1992 Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. Clinical Endocrinology 36 579-583.
36. Cooper-Kazaz R, van der Deure W, Medici M, Visser TJ, Alkelai A, Glaser B, Peeters RP & Lerer B 2009 Preliminary evidence that a functional polymorphism in type 1 deiodinase is associated with enhanced potentiation of the antidepressant effect of sertraline by triiodothyronine. Journal of Affective Disorders 16 113-116.
37. Corvilain B, Contempré B, Longombé AO, Goyens P, Gervy-Decoster C, Lamy F, Vanderpas JB & Dumont JE 1993 Selenium and the thyroid: how the relationship was established. American Journal of Clinical Nutrition 57 244S-248S.
38. Cusin I, Rouru J, Visser T, Burger AG & Rohner-Jeanrenaud F 2000 Involvement of thyroid hormones in the effect of intracerebroventricular leptin infusion on uncoupling protein-3 expression in rat muscle. Diabetes 49 1101-1105.
39. Darras VM, Visser TJ, Berghman LR & Kuhn ER 1992 Ontogeny of type I and type III deiodinase activities in embryonic and posthatch chicks: relationship with changes in plasma triiodothyronine and growth hormone levels. Comparative Biochemistry and Physiology. A, Comparative Physiology 103 131-136.
40. Davies PH, Black EG, Sheppard MC & Franklyn JA 1996a Relation between serum interleukin-6 and thyroid hormone concentrations in 270 hospital in-patients with non-thyroidal illness. Clinical Endocrinology 44 199-205.
41. Davies PH, Sheppard MC & Franklyn JA 1996b Regulation of type I 5′-deiodinase by thyroid hormone and dexamethasone in rat liver and kidney cells. Thyroid 6 221-228.
42. Davies TF, Ando T, Lin RY, Tomer Y & Latif R 2005 Thyrotropin receptorassociated diseases: from adenomata to Graves disease. Journal of Clinical nvestigation 115 1972-1983.
43. Debaveye Y, Ellger B, Mebis L, Darras VM & Van den Berghe G 2008Regulation of tissue iodothyronine deiodinase activity in a model of prolonged critical llness. Thyroid 18 551-560.
44. Debski MG, Pachucki J, Ambroziak M, OlszewskiW & Bar-Andziak E 2007 Human breast cancer tissue expresses high level of type 1 5′-deiodinase. hyroid 17 3-10.
45. Dentice M, Ambrosio R & Salvatore D 2009 Role of type 3 deiodinase in cancer. Expert Opinion on Therapeutic Targets 13 1363-1373.
46. DePalo D, Kinlaw WB, Zhao C, Engelberg-Kulka H & St Germain DL 1994 Effect of selenium deficiency on type I 5′-deiodinase. Journal of Biological hemistry 269 16223-16228.
47. Dora JM, Machado WE, Rheinheimer J, Crispim D & Maia AL 2010 Association of the type 2 deiodinase Thr92Ala polymorphism with type 2 diabetes: case-control study and meta-analysis. European Journal of Endocrinology 163 427-434.
48. Doyle KP, Suchland KL, Ciesielski TM, Lessov NS, Grandy DK, Scanlan TS & Stenzel-Poore MP 2007 Novel thyroxine derivatives, thyronamine and 3-iodothyronamine, induce transient hypothermia and marked neuroprotection against stroke injury. Stroke 38 2569-2576.
49. Duntas LH 2010 Selenium and the thyroid: a close-knit connection. Journal of Clinical Endocrinology and Metabolism 95 5180-5188.
50. Dutkiewicz S, Witeska A & Nauman A 1995 The deiodination of thyroxine to triiodothyronine in the testes of patients with prostate cancer. International rology and Nephrology 27 81-85.
51. Galton VA, Schneider MJ, Clark AS & St Germain DL 2009 Life without thyroxine to 3,5,3′-triiodothyronine conversion: studies in mice devoid of the 5′-deiodinases. Endocrinology 150 2957-2963.
52. Garcia-Solis P & Aceves C 2003 5′Deiodinase in two breast cancer cell lines: effect of triiodothyronine, isoproterenol and retinoids. Molecular and Cellular ndocrinology. 201 25-31.
53. Geffner DL, Azukizawa M & Hershman JM 1975 Propylthiouracil blocks extrathyroidal conversion of thyroxine to triiodothyronine and augments thyrotropin secretion in man. Journal of Clinical Investigation 55 224-229.
54. Gereben B, Goncalves C, Harney JW, Larsen PR & Bianco AC 2000 Selective proteolysis of human type 2 deiodinase: a novel ubiquitin-proteasomal mediated mechanism for regulation of hormone activation. Molecular Endocrinology 14 1697-1708.
55. Goemann IM, Gereben B, Harney JW, Zhu B, Maia AL & Larsen PR 2010 Substitution of serine for proline in the active center of type 2 iodothyronine deiodinase substantially alters its in vitro biochemical properties with dithiothreitol but not its function in intact cells. Endocrinology 151 821-829.
56. Goswami A & Rosenberg IN 1984 Iodothyronine 5′-deiodinase in rat kidney microsomes. Kinetic behavior at low substrate concentrations. Journal of linical Investigation 74. 2097-2106.
57. Goswami A & Rosenberg IN 1987 Thioredoxin stimulates enzymatic outer ring monodeiodination of reverse triiodothronine. Endocrinology 121. 1937-1945.
58. Goyens P, Golstein J, Nsombola B, Vis H & Dumont JE 1987 Selenium deficiency as a possible factor in the pathogenesis of myxoedematous endemic retinism. Acta Endocrinologica 114 497-502.
59. 3 onversion in the rat. Metabolism 27 1680-1690.
60. Huang TS, Chopra IJ, Boado R, Soloman DH & Chua Teco GN 1988 Thyroxine inner ring monodeiodination activity in fetal tissues of the rat. Pediatric esearch 23. 196-199.
61. Inada M, Kasagi K, Kurata S, Kazama Y, Takayama H, Torizuka K, Fukase M & Soma T 1975 Estimation of thyroxine and triiodothyronine distribution and of the conversion rate of thyroxine to triiodothyronine in man. Journal of Clinical Investigation 55 1337-1348.
62. Ishii H, Inada M, Tanaka K, Mashio Y, Naito K, Nishikawa M, Matsuzuka F, Kuma K & Imura H 1983 Induction of outer and inner ring monodeiodinases in human thyroid gland by thyrotropin. Journal of Clinical Endocrinology and Metabolism 57 500-505.
63. Ito M, Toyoda N, Nomura E, Takamura Y, Amino N, Iwasaka T, Takamatsu J, Miyauchi A & Nishikawa M 2011 Type 1 and type 2 iodothyronine deiodinases in the thyroid gland of patients with 3,5,3′-triiodothyroninepredominant Graves' disease. European Journal of Endocrinology 164 95-100.
64. Jakobs TC, Koehler MR, Schmutzler C, Glaser F, Schmid M & Kohrle J 1997a Structure of the human type I iodothyronine 5′-deiodinase gene and ocalization to chromosome 1p32-p33. Genomics 42 361-363.
65. Jakobs TC, Schmutzler C, Meissner J & Kohrle J 1997b The promoter of the human type I 5′-deiodinase gene - mapping of the transcription start site and identification of a DR +4 thyroid-hormone-responsive element. European Journal of Biochemistry 247 288-297.
66. Jakobs TC, Mentrup B, Schmutzler C, Dreher I & Kohrle J 2002 Proinflammatory cytokines inhibit the expression and function of human type I 5′-deiodinase in HepG2 hepatocarcinoma cells. European Journal of Endocrinology 146 559-566.
67. Janssen KP, Van Der Heide D, Visser TJ, Kaptein E & Beynen AC 1994 Thyroid function and deiodinase activities in rats with marginal iodine deficiency. Biological Trace Element Research 40 237-246.
68. Jochum F, Terwolbeck K, Meinhold H, Behne D, Menzel H & Lombeck I 1997 Effects of a low selenium state in patients with phenylketonuria. Acta aediatrica 86 775-777.
69. de Jong FJ, Peeters RP, den Heijer T, van der Deure WM, Hofman A, Uitterlinden AG, Visser TJ & Breteler MM 2007 The association of polymorphisms in the type 1 and 2 deiodinase genes with circulating thyroid hormone parameters and atrophy of the medial temporal lobe. Journal of Clinical Endocrinology and etabolism 92 636-640.
70. Jorgensen JO, Pedersen SA, Laurberg P,Weeke J, Skakkebaek NE & Christiansen JS 1989 Effects of growth hormone therapy on thyroid function of growth hormone-deficient adults with and without concomitant thyroxinesubstituted central hypothyroidism. Journal of Clinical Endocrinology and Metabolism 69 1127-132.
71. Kaplan MM & Utiger RD 1978 Iodothyronine metabolism in liver and kidney homogenates from hyperthyroid and hypothyroid rats. Endocrinology 103 156-61.
72. Kaptein EM, Fisler JS, Duda MJ, Nicoloff JT & Drenick EJ 1985 Relationship between the changes in serum thyroid hormone levels and protein status during prolonged protein supplemented caloric deprivation. Clinical Endocrinology 22 1-15.
73. Kauf E, Dawczynski H, Jahreis G, Janitzky E & Winnefeld K 1994 Sodium selenite therapy and thyroid-hormone status in cystic fibrosis and congenital ypothyroidism. Biological Trace Element Research 40 247-253.
74. Kester MH, Martinez de Mena R, Obregon MJ, Marinkovic D, Howatson A, Visser TJ, Hume R & Morreale de Escobar G 2004 Iodothyronine levels in the human developing brain: major regulatory roles of iodothyronine deiodinases in different areas. Journal of Clinical Endocrinology and Metabolism 89 3117-3128.
75. Kim SW, Harney JW & Larsen PR 1998 Studies of the hormonal regulation of type 2 5′-iodothyronine deiodinase messenger ribonucleic acid in pituitary tumor cells using semiquantitative reverse transcription-polymerase chain reaction. Endocrinology 139 4895-4905.
76. Koenig RJ 2005 Regulation of type 1 iodothyronine deiodinase in health and disease. Thyroid 15 835-840.
77. Kohrle J 1997 Thyroid carcinoma: interrelationships between local thyroid hormone metabolism by the type I 5′-deiodinase and the expression of thyroid hormone receptors and other thyroid-specific (de-)differentiation markers. Current Topics in Pathology 91 83-116.
78. Kornasiewicz O, Debski M, Stepnowska M, Szalas A, Bar-Andziak E & Krawczyk M 2010 The enzymatic activity of type 1 iodothyronine deiodinase (D1) is lowin liver hemangioma: a preliminary study. Archivum Immunologiae et Therapiae Experimentalis 58 77-80.
79. Krohn K, Fuhrer D, Bayer Y, Eszlinger M, Brauer V, Neumann S & PaschkeR 2005 Molecular pathogenesis of euthyroid and toxic multinodular goiter. ndocrine Reviews 26 504-524.
80. Kwakkel J, van Beeren HC, Ackermans MT, Platvoet-Ter Schiphorst MC, Fliers E, Wiersinga WM & Boelen A 2009 Skeletal muscle deiodinase type 2 regulation during illness in mice. Journal of Endocrinology. 203 263-270.
81. Larsen PR 1972 Triiodothyronine: review of recent studies of its physiology and pathophysiology in man. Metabolism 21 1073-1092.
82. Larsen PR, Silva JE & Kaplan MM 1981 Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. ndocrine Reviews 2 87-102.
83. 3) from dog thyroid. ndocrinology 102 757-766.
84. Laurberg P, Vestergaard H, Nielsen S, Christensen SE, Seefeldt T, Helleberg K & Pedersen KM 2007 Sources of circulating 3,5,3′-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases. Journal of Clinical Endocrinology and Metabolism 92 2149-2156.
85. Laurberg P,Wallin G,Tallstedt L, Abraham-Nordling M, Lundell G&Torring O 2008 TSH-receptor autoimmunity in Graves' disease after therapy with antithyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study. European Journal of Endocrinology 158 69-75.
86. Legradi G, Emerson CH, Ahima RS, Flier JS & Lechan RM 1997 Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 138 2569-2576.
87. Leonard JL&Rosenberg IN 1980 Iodothyronine 5′-deiodinase from rat kidney: substrate specificity and the 5′-deiodination of reverse triiodothyronine. Endocrinology 107 1376-1383.
88. Leonard JL & Visser TJ 1986 Biochemistry of deiodination. In Thyroid Hormone Metabolism, pp 189-229. Ed. GHennemann.New York:Marcel Dekker, nc.
89. Leonard JL, Ekenbarger DM, Frank SJ, Farwell AP & Koehrle J 1991Localization of type I iodothyronine 5′-deiodinase to the basolateral plasma membrane in renal cortical epithelial cells. Journal of Biological Chemistry 266 11262-11269.
90. Leonard JL, Visser TJ & Leonard DM 2001 Characterization of the subunit structure of the catalytically active type I iodothyronine deiodinase. Journal of iological Chemistry 276 2600-2607.
91. Lombeck I, Jochum F & Terwolbeck K 1996 Selenium status in infants and children with phenylketonuria and in maternal phenylketonuria. European Journal f Pediatrics 155 (Suppl 1) S140-S144.
92. LoPresti JS, Eigen A, Kaptein E, Anderson KP, Spencer CA & Nicoloff JT 1989 Alterations in 3,3′5′-triiodothyronine metabolism in response to propylthiouracil, dexamethasone, and thyroxine administration in man. Journal of Clinical Investigation 84 1650-1656.
93. Lum SM, Nicoloff JT, Spencer CA & Kaptein EM 1984 Peripheral tissue mechanism for maintenance of serum triiodothyronine values in a thyroxine-deficient state in man. Journal of Clinical Investigation 73 570-575.
94. Macejova D, Liska J & Brtko J 2001 Mammary gland carcinoma-related increase of type I iodothyronine 5′-deiodinase activity in Sprague-Dawley rats. eneral Physiology and Biophysics. 20 293-302.
95. 3 in hyperthyroidism: implications for therapy. Nature Clinical Practice. ndocrinology & Metabolism 3 740-741.
96. Maia AL, Berry MJ, Sabbag R, Harney JW & Larsen PR 1995a Structural and functional differences in the dio1 gene in mice with inherited type 1 eiodinase deficiency. Molecular Endocrinology 9 969-980.
97. Maia AL, Harney JW & Larsen PR 1995b Pituitary cells respond to thyroid hormone by discrete, gene-specific pathways. Endocrinology 136 1488- 1494.
98. 3 metabolism in normal and type 1 deiodinase-deficient mice. Endocrinology 136 4842-4849.
99. 3 in euthyroid humans. ournal of Clinical Investigation 115 2524-2533.
100. Mandel SJ, Berry MJ, Kieffer JD, Harney JW, Warne RL & Larsen PR 1992 Cloning and in vitro expression of the human selenoprotein, type I iodothyronine deiodinase. Journal of Clinical Endocrinology and Metabolism 75 1133-1139.
101. Meinhold H, Campos-Barros A & Behne D 1992 Effects of selenium and iodine deficiency on iodothyronine deiodinases in brain, thyroid and peripheral issue. Acta Medica Austriaca. 19 (Suppl 1) 8-12.
102. Menjo M, Murata Y, Fujii T, Nimura Y & Seo H 1993 Effects of thyroid and glucocorticoid hormones on the level of messenger ribonucleic acid for iodothyronine type I 5′-deiodinase in rat primary hepatocyte cultures grown as spheroids. Endocrinology 133 2984-2990.
103. Meyer EL, Wagner MS & Maia AL 2007 Iodothyronine deiodinases expression in thyroid neoplasias. Arquivos Brasileiros de Endocrinologia e Metabologia 1 690-700.
104. Mol JA & Visser TJ 1985 Rapid and selective inner ring deiodination of thyroxine sulfate by rat liver deiodinase. Endocrinology 117 8-12.
105. Mori K, Stone S, Braverman LE & DevitoWJ 1996 Involvement of tyrosine phosphorylation in the regulation of 5′-deiodinases inFRTL-5 rat thyroid cells nd rat astrocytes. Endocrinology 137 1313-1318.
106. Nagaya T, FujiedaM,OtsukaG, Yang JP, Okamoto T&Seo H 2000 A potential role of activatedNF-kappa B in the pathogenesis of euthyroid sick syndrome. Journal of Clinical Investigation 106 393-402.
107. Nakamura H, Noh JY, Itoh K, Fukata S, Miyauchi A & Hamada N 2007 Comparison of methimazole and propylthiouracil in patients with hyperthyroidism caused by Graves' disease. Journal of Clinical Endocrinology and metabolism 92 2157-2162.
108. Nicoloff JT, Low JC, Dussault JH & Fisher DA 1972 Simultaneous measurement of thyroxine and triiodothyronine peripheral turnover kinetics in man. Journal of Clinical Investigation 51 473-483.
109. 3 in hyperthyroid Graves' disease. Biochemical and Biophysical Research Communications 250 642-646.
110. Ohguchi H, Tanaka T, Uchida A, Magoori K, Kudo H, Kim I, Daigo K, Sakakibara I, Okamura M, Harigae H et al. 2008 Hepatocyte nuclear factor 4alpha contributes to thyroid hormone homeostasis by cooperatively regulating the type 1 iodothyronine deiodinase gene with GATA4 and Kruppel-like transcription factor 9. Molecular and Cellular Biology 28 3917-3931.
111. Olivares EL, Marassi MP, Fortunato RS, da Silva AC, Costa-e-Sousa RH, Araujo IG, Mattos EC, Masuda MO, Mulcahey MA, Huang SA et al. 2007 Thyroid function disturbance and type 3 iodothyronine deiodinase induction after myocardial infarction in rats a time course study. Endocrinology 148 4786-4792.
112. O'Mara BA, Dittrich W, Lauterio TJ & St Germain DL 1993 Pretranslational regulation of type I 5′-deiodinase by thyroid hormones and in fasted and iabetic rats. Endocrinology 133 1715-1723.
113. Otten MH, Mol JA & Visser TJ 1983 Sulfation preceding deiodination of iodothyronines in rat hepatocytes. Science 221 81-83.
114. Otten MH, Hennemann G, Docter R & Visser TJ 1984 Metabolism of 3,3′-diiodothyronine in rat hepatocytes: interaction of sulfation with deiodination. Endocrinology 115 887-894.
115. Pachucki J, Ambroziak M, Tanski Z, Luczak J, Nauman J & Nauman A 2001 Type I 5′-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma. Journal of Endocrinological Investigation 24 253-261.
116. Panicker V, Cluett C, Shields B, Murray A, Parnell KS, Perry JR, Weedon MN, Singleton A, Hernandez D, Evans J et al. 2008 A common variation in deiodinase 1 gene DIO1 is associated with the relative levels of free thyroxine and triiodothyronine. Journal of Clinical Endocrinology and Metabolism 93 3075-3081.
117. Peeters RP, van Toor H, Klootwijk W, de Rijke YB, Kuiper GG, Uitterlinden AG & Visser TJ 2003a Polymorphisms in thyroid hormone pathway genes are associated with plasma TSH and iodothyronine levels in healthy subjects. Journal of Clinical Endocrinology and Metabolism 88 2880-2888.
118. Peeters RP, Wouters PJ, Kaptein E, van Toor H, Visser TJ & Van den Berghe G 2003b Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. Journal of Clinical Endocrinology and Metabolism 88 3202-3211.
119. Peeters RP, van den Beld AW, van Toor H, Uitterlinden AG, Janssen JA, Lamberts SW & Visser TJ 2005a A polymorphism in type I deiodinase is associated with circulating free insulin-like growth factor I levels and body composition in humans. Journal of Clinical Endocrinology and Metabolism 90 256-263.
120. Peeters RP, van der Geyten S, Wouters PJ, Darras VM, van Toor H, Kaptein E, Visser TJ & Van den Berghe G 2005b Tissue thyroid hormone levels in critical illness. Journal of Clinical Endocrinology and Metabolism 90 6498-6507.
121. 3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. Journal of Clinical Endocrinology and Metabolism 0 4559-4565.
122. Peeters RP, van der DeureWM& Visser TJ 2006 Genetic variation in thyroid hormone pathway genes; polymorphisms in the TSH receptor and the iodothyronine deiodinases. European Journal of Endocrinology 155 655-662.
123. Pekary AE, Berg L, Santini F, Chopra I & Hershman JM 1994 Cytokines modulate type I iodothyronine deiodinase mRNA levels and enzyme activity in FRTL-5 rat thyroid cells. Molecular and Cellular Endocrinology 101 R31-R35.
124. Piehl S, Heberer T, Balizs G, Scanlan TS, Smits R, Koksch B & Köhrle J 2008 Thyronamines are isozyme-specific substrates of deiodinases. Endocrinology 49 3037-3045.
125. Piekielko-Witkowska A, Master A, Wojcicka A, Boguslawska J, Brozda I, Tanski Z & Nauman A 2009 Disturbed expression of type 1 iodothyronine deiodinase splice variants in human renal cancer. Thyroid. 19 1105-1113.
126. Portnay GI, O'Brian JT, Bush J, Vagenakis AG, Azizi F, Arky RA, Ingbar SH & Braverman LE 1974 The effect of starvation on the concentration and binding of thyroxine and triiodothyronine in serum and on the response to TRH. Journal of Clinical Endocrinology and Metabolism 39. 191-194.
127. Richard K, Hume R, Kaptein E, Sanders JP, van Toor H, De Herder WW, den Hollander JC, Krenning EP & Visser TJ 1998 Ontogeny of iodothyronine deiodinases in human liver. Journal of Clinical Endocrinology and Metabolism 83 2868-2874.
128. Riesco G, Taurog A & Larsen PR 1976 Variations in the response of the thyroid gland of the rat to different low-iodine diets: correlation with iodine content of diet. Endocrinology 99 270-280.
129. Rodriguez-Perez A, Palos-Paz F, Kaptein E, Visser TJ, Dominguez-Gerpe L, Alvarez-Escudero J & Lado-Abeal J 2008 Identification of molecular mechanisms related to nonthyroidal illness syndrome in skeletal muscle and adipose tissue from patients with septic shock. Clinical Endocrinology 68 821-827.
130. Rosenbaum M, Goldsmith R, Bloomfield D, Magnano A, Weimer L, Heymsfield S, Gallagher D, Mayer L, Murphy E & Leibel RL 2005 Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptations to maintenance of reduced weight. Journal of Clinical Investigation 115 3579-3586.
131. Sabatino L, Iervasi G, Ferrazzi P, Francesconi D & Chopra IJ 2000 A study of iodothyronine 5′-monodeiodinase activities in normal and pathological tissues in man and their comparison with activities in rat tissues. Life Sciences 68. 191-202.
132. Saberi M, Sterling FH & Utiger RD 1975 Reduction in extrathyroidal triiodothyronine production by propylthiouracil in man. Journal of Clinical Investigation 5 218-223.
133. Salvatore D, Tu H, Harney JW & Larsen PR 1996 Type 2 iodothyronine deiodinase is highly expressed in human thyroid. Journal of Clinical Investigation 98 62-968.
134. Sanders JP, Van der Geyten S, Kaptein E, Darras VM, Kuhn ER, Leonard JL & Visser TJ 1997 Characterization of a propylthiouracil-insensitive type I odothyronine deiodinase. Endocrinology 138 5153-5160.
135. Santini F, Chiovato L, Ghirri P, Lapi P, Mammoli C, Montanelli L, Scartabelli G, Ceccarini G, Coccoli L, Chopra IJ et al. 1999 Serum iodothyronines in the human fetus and the newborn: evidence for an important role of placenta in fetal thyroid hormone homeostasis. Journal of Clinical Endocrinology and Metabolism 84 93-498.
136. Scanlan TS 2009 Minireview: 3-iodothyronamine (T1AM): a new player on the thyroid endocrine team? Endocrinology 150 1108-1111
137. Scanlan TS, Suchland KL, Hart ME, Chiellini G, Huang Y, Kruzich PJ, Frascatelli S, Crossley DA II, Bunzow JR, Ronca-Testoni S et al. 2004 3-Iodothyronamine is an endogenous and rapid-acting derivative of thyroid hormone. Nature Medicine 10 638-642.
138. Schmutzler C, Hoang-Vu C, Ruger B & Kohrle J 2004 Human thyroid carcinoma cell lines show different retinoic acid receptor repertoires and retinoid esponses. European Journal of Endocrinology 150 547-556.
139. Schneider MJ, Fiering SN, Thai B, Wu SY, St Germain E, Parlow AF, St Germain DL & Galton VA 2006 Targeted disruption of the type 1 selenodeiodinase gene (Dio1) results in marked changes in thyroid
140. Schoenmakers CH, Pigmans IG, Poland A & Visser TJ 1993 Impairment of the selenoenzyme type I iodothyronine deiodinase in C3H/He mice. ndocrinology 132 357-361.
141. Schoenmakers CH, Pigmans IG & Visser TJ 1995 Investigation of type I and type III iodothyronine deiodinases in rat tissues using N-bromoacetyliodothyronine affinity labels. Molecular and Cellular Endocrinology 107 173-180.
142. Schreck R, Schnieders F, Schmutzler C & Kohrle J 1994 Retinoids stimulate type I iodothyronine 5′-deiodinase activity in human follicular thyroid carcinoma cell lines. Journal of Clinical Endocrinology and Metabolism 79 791-798.
143. Schröder-van der Elst JP, van der Heide D, Morreale de Escobar G & Obregón MJ 1998 Iodothyronine deiodinase activities in fetal rat tissues at several levels of iodine deficiency: a role for the skin in 3,5,3′-triiodothyronine economy? Endocrinology 139 2229-2234
144. Sharifi J & St Germain DL 1992 The cDNA for the type I iodothyronine 5′-deiodinase encodes an enzyme manifesting both high Km and low Km activity. Evidence that rat liver and kidney contain a single enzyme which converts thyroxine to 3,5,3′-triiodothyronine. Journal of Biological Chemistry 267 12539-12544.
145. Simonides WS, Mulcahey MA, Redout EM, Muller A, Zuidwijk MJ, Visser TJ, Wassen FW, Crescenzi A, da-Silva WS, Harney J et al. 2008 Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. Journal of Clinical Investigation 118 975-983.
146. de Souza Meyer EL, Dora JM,Wagner MS &Maia AL 2005 Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentiation towards papillary carcinoma. Clinical Endocrinology 62 672-678.
147. St Germain DL 1988 The effects and interactions of substrates, inhibitors, and the cellular thiol-disulfide balance on the regulation of type II iodothyronine 5′-eiodinase. Endocrinology 122 1860-1868.
148. St Germain DL & Croteau W 1989 Ligand-induced inactivation of type I iodothyronine 5′-deiodinase: protection by propylthiouracil in vivo and reversibility in vitro. Endocrinology 125 2735-2744.
149. St Germain DL & Galton VA 1985 Comparative study of pituitary-thyroid hormone economy in fasting and hypothyroid rats. Journal of Clinical Investigation 5 679-688.
150. St Germain DL & Galton VA 1997 The deiodinase family of selenoproteins. Thyroid 7 655-668.
151. Sun BC, Harney JW, Berry MJ & Larsen PR 1997 The role of the active site cysteine in catalysis by type 1 iodothyronine deiodinase. Endocrinology 138 452-5458.
152. Tannahill LA, Visser TJ, McCabe CJ, Kachilele S, Boelaert K, Sheppard MC, Franklyn JA & Gittoes NJ 2002 Dysregulation of iodothyronine deiodinase enzyme expression and function in human pituitary tumours. Clinical Endocrinology 56 735-743.
153. Tegler L, Anderberg B & Smeds S 1982 Preferential secretion of triiodothyronine in man. Hormone and Metabolic Research 14 593-595.
154. Torpy DJ, Tsigos C, Lotsikas AJ, Defensor R, Chrousos GP & Papanicolaou DA 1998 Acute and delayed effects of a single-dose injection of interleukin-6 on thyroid function in healthy humans. Metabolism 47 1289-1293.
155. Toyoda N, Nishikawa M, Mori Y, Yoshimura M, Masaki H, Gondou A, Yonemoto T & InadaM 1992 Identification of a 27-kilodalton protein with the properties of type I iodothyronine 5′-deiodinase in human thyroid gland. Journal of Clinical Endocrinology and Metabolism 74 533-538.
156. Toyoda N, Zavacki AM, Maia AL, Harney JW & Larsen PR 1995 A novel retinoid X receptor-independent thyroid hormone response element is present in the human type 1 deiodinase gene. Molecular and Cellular Biology 15 5100-5112.
157. Toyoda N, Kaptein E, Berry MJ, Harney JW, Larsen PR & Visser TJ 1997 Structure-activity relationships for thyroid hormone deiodination by mammalian type I iodothyronine deiodinases. Endocrinology 138 213-219.
158. Van der Deure WM, Hansen PS, Peeters RP, Uitterlinden AG, Fenger M, Kyvik KO, Hegedüs L & Visser TJ 2009 The effect of genetic variation in the type 1 deiodinase gene on the interindividual variation in serum thyroid hormone levels: an investigation in healthy Danish twins. Clinical Endocrinology 70 954-960.
159. Van der Geyten S, Buys N, Sanders JP, Decuypere E, Visser TJ, Kuhn ER & Darras VM 1999 Acute pretranslational regulation of type III iodothyronine deiodinase by growth hormone and dexamethasone in chicken embryos. Molecular and Cellular Endocrinology 147 49-56.
160. Van der Geyten S, Byamungu N, Reyns GE, Kuhn ER & Darras VM 2005 Iodothyronine deiodinases and the control of plasma and tissue thyroid hormone levels in hyperthyroid tilapia (Oreochromis niloticus). Journal of Endocrinology 184 467-479.
161. Vanderpas JB, Contempre B, Duale NL, Goossens W, Bebe N, Thorpe R, Ntambue K, Dumont J, Thilly CH & Diplock AT 1990 Iodine and selenium deficiency associated with cretinism in northern Zaire. American Journal of Clinical Nutrition 52 1087-1093.
162. Vignati L, Finley RJ, Hagg S & Aoki TT 1978 Protein conservation during prolonged fast: a function of triiodothyronine levels. Transactions of the ssociation of American Physicians 91 169-179.
163. Visser TJ, Does-Tobe I, Docter R & Hennemann G 1976 Subcellular localization of a rat liver enzyme converting thyroxine into triiodothyronine and possible involvement of essential thiol groups. Biochemical Journal 157 479-482.
164. Visser TJ, Fekkes D, Docter R & Hennemann G 1978 Sequential deiodination of thyroxine in rat liver homogenate. Biochemical Journal 174 221-229.
165. Visser TJ, Fekkes D, Docter R & Hennemann G 1979 Kinetics of enzymic reductive deiodination of iodothyronines. Effect of pH. Biochemical Journal 179 89-495.
166. Visser TJ, Kaptein E, Terpstra OT & Krenning EP 1988 Deiodination of thyroid hormone by human liver. Journal of Clinical Endocrinology and Metabolism 7 17-24.
167. Wagner MS,Wajner SM, Dora JM &Maia AL 2007 Regulation of Dio2 gene expression by thyroid hormones in normal and type 1 deiodinase-deficient 3H mice. Journal of Endocrinology. 193 435-444.
168. Wagner MS, Wajner SM & Maia AL 2008 The role of thyroid hormone in testicular development and function. Journal of Endocrinology. 199 351-365.
169. Warner MH & Beckett GJ 2010 Mechanisms behind the non-thyroidal illness syndrome: an update. Journal of Endocrinology. 205 1-13.
170. Wawrzynska L, Sakowicz A, Rudzinski P, Langfort R & Kurzyna M 2003 The conversion of thyroxine to triiodothyronine in the lung: comparison of activity of type I iodothyronine 5′ deiodinase in lung cancer with peripheral lung tissues. Monaldi Archives for Chest Disease 59 140-145.
171. Woeber KA 2006 Triiodothyronine production in Graves' hyperthyroidism. Thyroid 16 687-690.
172. Yang XF, Hou XH, Xu J, Guo HL, Yinq CJ, Chen XY & Sun XF 2006 Effect of selenium supplementation on activity and mRNA expression of type 1 deiodinase in mice with excessive iodine intake. Biomedical and Environmental Sciences. 19 302-308.
173. 3 and nuclear receptor coactivators as a model of the sick euthyroid yndrome. Journal of Biological Chemistry 275 38296-38301.
174. Yu J & Koenig RJ 2006 Induction of type 1 iodothyronine deiodinase to prevent the nonthyroidal illness syndrome in mice. Endocrinology 147 3580-3585.
175. Zhang CY, Kim S, Harney JW & Larsen PR 1998 Further characterization of thyroid hormone response elements in the human type 1 iodothyronine eiodinase gene. Endocrinology 139 1156-1163.